Endocrinology News

Children with hypochondroplasia had an increase in growth velocity at 1 year of treatment with vosoritide, according to findings from a phase 2 trial.

Among patients with diabetes undergoing emergency surgery, the risk for respiratory complications afterward was not heightened with glucagon-like peptide-1 receptor agonist use, according to a research letter published in JAMA.

Men who consumed more dietary vitamin E may be less likely to develop subclinical hypothyroidism and autoimmune thyroiditis, though no associations were observed among women, according to findings published in Thyroid.

Premature surgical menopause may increase the likelihood of musculoskeletal discomfort and sarcopenia, highlighting the potential importance of hormones in postmenopausal musculoskeletal health, researchers reported in Menopause.

Adults who initiate a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those prescribed a DPP-IV inhibitor or an SGLT2 inhibitor, according to study findings published in The BMJ.

DENVER — Losing weight is good for patients’ wallets as well as their health, according to a presenter at the Obesity Medicine Association’s annual conference.

The FDA granted fast track designation for an investigational parathyroid hormone 1 receptor agonist to treat hypoparathyroidism, according to an industry press release.

Dietary supplements marketed online to promote weight loss commonly have inaccurate labels and may include unsafe ingredients for the public to use, according to findings published in JAMA Network Open.

In this video, Katherine Saunders, MD, DABOM, discusses how obesity awareness has evolved since obesity was recognized as a disease in 2013.

In this video, Katherine Saunders, MD, DABOM, discusses the need for clinicians who are "culturally competent" and provide evidence-based, comprehensive obesity treatment.